CHG-2022-0139

Facility Change for Brextanib. Container Closure Change for Brextanib — critical change. Impacts 5 markets and 2 variations.

Change Number
CHG-2022-0139
Type
Facility Change
Product
Brextanib
Status
Submitted
Owner
James O'Brien
Initiated
2022-08-14
Description

Container Closure Change for Brextanib — critical change

Impacted Markets (5)
GB — United KingdomMX — MexicoZA — South AfricaPT — PortugalDK — Denmark
Impacted Modules
3.2.P.34.2.13.2.S3.2.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved